Cargando…

Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study

OBJECTIVES: To investigate the role of risk assessment in predicting suicide in patients with schizophrenia spectrum disorders (SSDs) receiving secondary mental healthcare. We postulated that risk assessment plays a limited role in predicting suicide in these patients. DESIGN: Retrospective case–con...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Morinigo, Javier-David, Ayesa-Arriola, Rosa, Torres-Romano, Beatriz, Fernandes, Andrea C, Shetty, Hitesh, Broadbent, Matthew, Dominguez-Ballesteros, Maria-Encarnacion, Stewart, Robert, David, Anthony S, Dutta, Rina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051464/
https://www.ncbi.nlm.nih.gov/pubmed/27678536
http://dx.doi.org/10.1136/bmjopen-2016-011929
_version_ 1782458081716731904
author Lopez-Morinigo, Javier-David
Ayesa-Arriola, Rosa
Torres-Romano, Beatriz
Fernandes, Andrea C
Shetty, Hitesh
Broadbent, Matthew
Dominguez-Ballesteros, Maria-Encarnacion
Stewart, Robert
David, Anthony S
Dutta, Rina
author_facet Lopez-Morinigo, Javier-David
Ayesa-Arriola, Rosa
Torres-Romano, Beatriz
Fernandes, Andrea C
Shetty, Hitesh
Broadbent, Matthew
Dominguez-Ballesteros, Maria-Encarnacion
Stewart, Robert
David, Anthony S
Dutta, Rina
author_sort Lopez-Morinigo, Javier-David
collection PubMed
description OBJECTIVES: To investigate the role of risk assessment in predicting suicide in patients with schizophrenia spectrum disorders (SSDs) receiving secondary mental healthcare. We postulated that risk assessment plays a limited role in predicting suicide in these patients. DESIGN: Retrospective case–control study. SETTING: Anonymised electronic mental health record data from the South London and Maudsley National Health Service (NHS) Foundation Trust (SLaM) (London, UK) linked with national mortality data. PARTICIPANTS: In 242 227 SLaM service users up to 31 December 2013, 635 suicides were identified. 96 (15.1%) had a SSD diagnosis. Those who died before 1 January 2007 (n=25) were removed from the analyses. Thus, 71 participants with SSD who died from suicide over the study period (cases) were compared with 355 controls. MAIN OUTCOME MEASURE: Risk of suicide in relation to risk assessment ratings. RESULTS: Cases were younger at first contact with services (mean±SD 34.5±12.6 vs 39.2±15.2) and with a higher preponderance of males (OR=2.07, 95% CI 1.18 to 3.65, p=0.01) than controls. Also, suicide occurred within 10 days after last contact with services in half of cases, with the most common suicide methods being hanging (14) and jumping (13). Cases were more likely to have the following ‘risk assessment’ items previously recorded: suicidal history (OR=4.42, 95% CI 2.01 to 9.65, p<0.001), use of violent method (OR=3.37, 95% CI 1.47 to 7.74, p=0.01), suicidal ideation (OR=3.57, 95% CI 1.40 to 9.07, p=0.01) and recent hospital discharge (OR=2.71, 95% CI 1.17 to 6.28, p=0.04). Multiple regression models predicted only 21.5% of the suicide outcome variance. CONCLUSIONS: Predicting suicide in schizophrenia is highly challenging due to the high prevalence of risk factors within this diagnostic group irrespective of outcome, including suicide. Nevertheless, older age at first contact with mental health services and lack of suicidal history and suicidal ideation are useful protective markers indicative of those less likely to end their own lives.
format Online
Article
Text
id pubmed-5051464
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50514642016-10-17 Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study Lopez-Morinigo, Javier-David Ayesa-Arriola, Rosa Torres-Romano, Beatriz Fernandes, Andrea C Shetty, Hitesh Broadbent, Matthew Dominguez-Ballesteros, Maria-Encarnacion Stewart, Robert David, Anthony S Dutta, Rina BMJ Open Mental Health OBJECTIVES: To investigate the role of risk assessment in predicting suicide in patients with schizophrenia spectrum disorders (SSDs) receiving secondary mental healthcare. We postulated that risk assessment plays a limited role in predicting suicide in these patients. DESIGN: Retrospective case–control study. SETTING: Anonymised electronic mental health record data from the South London and Maudsley National Health Service (NHS) Foundation Trust (SLaM) (London, UK) linked with national mortality data. PARTICIPANTS: In 242 227 SLaM service users up to 31 December 2013, 635 suicides were identified. 96 (15.1%) had a SSD diagnosis. Those who died before 1 January 2007 (n=25) were removed from the analyses. Thus, 71 participants with SSD who died from suicide over the study period (cases) were compared with 355 controls. MAIN OUTCOME MEASURE: Risk of suicide in relation to risk assessment ratings. RESULTS: Cases were younger at first contact with services (mean±SD 34.5±12.6 vs 39.2±15.2) and with a higher preponderance of males (OR=2.07, 95% CI 1.18 to 3.65, p=0.01) than controls. Also, suicide occurred within 10 days after last contact with services in half of cases, with the most common suicide methods being hanging (14) and jumping (13). Cases were more likely to have the following ‘risk assessment’ items previously recorded: suicidal history (OR=4.42, 95% CI 2.01 to 9.65, p<0.001), use of violent method (OR=3.37, 95% CI 1.47 to 7.74, p=0.01), suicidal ideation (OR=3.57, 95% CI 1.40 to 9.07, p=0.01) and recent hospital discharge (OR=2.71, 95% CI 1.17 to 6.28, p=0.04). Multiple regression models predicted only 21.5% of the suicide outcome variance. CONCLUSIONS: Predicting suicide in schizophrenia is highly challenging due to the high prevalence of risk factors within this diagnostic group irrespective of outcome, including suicide. Nevertheless, older age at first contact with mental health services and lack of suicidal history and suicidal ideation are useful protective markers indicative of those less likely to end their own lives. BMJ Publishing Group 2016-09-27 /pmc/articles/PMC5051464/ /pubmed/27678536 http://dx.doi.org/10.1136/bmjopen-2016-011929 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Mental Health
Lopez-Morinigo, Javier-David
Ayesa-Arriola, Rosa
Torres-Romano, Beatriz
Fernandes, Andrea C
Shetty, Hitesh
Broadbent, Matthew
Dominguez-Ballesteros, Maria-Encarnacion
Stewart, Robert
David, Anthony S
Dutta, Rina
Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study
title Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study
title_full Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study
title_fullStr Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study
title_full_unstemmed Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study
title_short Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study
title_sort risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case–control study
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051464/
https://www.ncbi.nlm.nih.gov/pubmed/27678536
http://dx.doi.org/10.1136/bmjopen-2016-011929
work_keys_str_mv AT lopezmorinigojavierdavid riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT ayesaarriolarosa riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT torresromanobeatriz riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT fernandesandreac riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT shettyhitesh riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT broadbentmatthew riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT dominguezballesterosmariaencarnacion riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT stewartrobert riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT davidanthonys riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy
AT duttarina riskassessmentandsuicidebypatientswithschizophreniainsecondarymentalhealthcareacasecontrolstudy